"L’Institut Curie, acteur de référence de la lutte contre le cancer, associe un Centre de Recherche de renommée internationale et un Ensemble Hospitalier de pointe qui prend en charge tous les cancers, y compris les plus rares. Fondé en 1909 par Marie Curie, l’Institut Curie rassemble sur trois sites (Paris, Saint-Cloud, Orsay) plus de 3 300 chercheurs, médecins et soignants autour de trois missions : la recherche, les soins et la conservation et la transmission des savoirs. Fondation privée reconnue d’utilité publique habilitée à recevoir des dons et des legs, l’Institut Curie peut, grâce au soutien de ses donateurs, favoriser les découvertes et ainsi améliorer les traitements et la qualité de vie des malades."

During the past decade, Institut Curie conducted 243 clinical trials. In the 10-year time frame, 243 clinical trials started and 31 clinical trials were completed, i.e. on average, 12.8% percent of trials that started reached the finish line to date. In the past 5 years, 118 clinical trials started and 15 clinical trials were completed. i.e. 12.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Curie" #1 sponsor was "Institut Curie" with 79 trials, followed by "UNICANCER" with 39 trials sponsored, "Centre Leon Berard" with 27 trials sponsored, "Centre Oscar Lambret" with 17 trials sponsored and "Intergroupe Francophone de Cancerologie Thoracique" with 17 trials sponsored. Other sponsors include 222 different institutions and companies that sponsored additional 102 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Curie" #1 collaborator was "National Cancer Institute, France" with 18 trials as a collaborator, "AstraZeneca" with 15 trials as a collaborator, "Merck Sharp & Dohme LLC" with 12 trials as a collaborator, "Institut Curie" with 10 trials as a collaborator and "Bristol-Myers Squibb" with 9 trials as a collaborator. Other collaborators include 281 different institutions and companies that were collaborators in the rest 199 trials.

According to Clinical.Site data, the most researched conditions in "Institut Curie" are "Breast Cancer" (30 trials), "Cancer" (18 trials), "Metastatic Breast Cancer" (12 trials), "Neuroblastoma" (10 trials) and "Carcinoma, Non-Small-Cell Lung" (9 trials). Many other conditions were trialed in "Institut Curie" in a lesser frequency.

Most popular intervention types in "Institut Curie" are "Drug" (249 trials), "Other" (67 trials), "Procedure" (34 trials), "Radiation" (29 trials) and "Biological" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Carboplatin" (17 trials), "Blood sampling" (12 trials), "Cisplatin" (10 trials) and "Pemetrexed" (10 trials). Other intervention names were less common.

The vast majority of trials in "Institut Curie" are 315 trials for "All" genders, 76 trials for "Female" genders and 12 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Curie". 2 are not yet recruiting, 135 are recruiting, 57 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 156 completed trials in Institut Curie, 2 suspended trials, and 28 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Curie, 72 "Phase 1" clinical trials were conducted, 148 "Phase 2" clinical trials and 70 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 89 trials that are defined as “Not Applicable".

Institut Curie has several departments that took part in Clinical trials: "Institut Curie; Oncologie Medicale" - 37 trials, "Institut Curie, Oncologie Pédiatrique" - 2 trials